Drug Discovery and Development Analysis & Statistics, September 2012 (p50)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

1471-1500 of about 1 700 reports

Purchase Reports From Reputable Market Research Publishers

Triple Analysis: Pancreatic Cancer, Prostate Cancer and Angiogenesis

Triple Analysis: Pancreatic Cancer, Prostate Cancer and Angiogenesis

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts ...

  • Industries : Drug and Medication, General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Pancreatic Cancer, Prostate Cancer and Protein Kinase Inhibitors

Triple Analysis: Pancreatic Cancer, Prostate Cancer and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : General Medicine and Specialty Medicine, Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Prostate Cancer, Apoptosis and Angiogenesis

Triple Analysis: Prostate Cancer, Apoptosis and Angiogenesis

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Each of these three individual parts is ...

  • Industries : Drug and Medication, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine
Triple Analysis: Prostate Cancer, Apoptosis and Protein Kinase Inhibitors

Triple Analysis: Prostate Cancer, Apoptosis and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : Drug and Medication, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine, Therapy
Triple Analysis: Prostate Cancer, Angiogenesis and Protein Kinase Inhibitors

Triple Analysis: Prostate Cancer, Angiogenesis and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : Drug and Medication, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine, Therapy
Triple Analysis: Breast Cancer, Colorectal Cancer and Prostate Cancer

Triple Analysis: Breast Cancer, Colorectal Cancer and Prostate Cancer

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Colorectal Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication, Drug Discovery and Development
Triple Analysis: Breast Cancer, Leukemia and Prostate Cancer

Triple Analysis: Breast Cancer, Leukemia and Prostate Cancer

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Leukemia and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria in ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication, Drug Discovery and Development, General Medicine and Specialty Medicine
Triple Analysis: Breast Cancer, Lung Cancer and Prostate Cancer

Triple Analysis: Breast Cancer, Lung Cancer and Prostate Cancer

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Lung Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Lymphoma and Prostate Cancer

Triple Analysis: Breast Cancer, Lymphoma and Prostate Cancer

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Lymphoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria in ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication, Drug Discovery and Development
Triple Analysis: Breast Cancer, Pancreatic Cancer and Prostate Cancer

Triple Analysis: Breast Cancer, Pancreatic Cancer and Prostate Cancer

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Pancreatic Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Prostate Cancer and Apoptosis

Triple Analysis: Breast Cancer, Prostate Cancer and Apoptosis

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication, Pharmaceutical, General Medicine and Specialty Medicine, Pathology, Drug Discovery and Development
Triple Analysis: Breast Cancer, Prostate Cancer and Angiogenesis

Triple Analysis: Breast Cancer, Prostate Cancer and Angiogenesis

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Prostate Cancer and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is ...

  • Industries : Drug and Medication, Pharmaceutical, General Medicine and Specialty Medicine, Pathology, Drug Discovery and Development
Triple Analysis: Breast Cancer, Prostate Cancer and Protein Kinase Inhibitors

Triple Analysis: Breast Cancer, Prostate Cancer and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : Drug and Medication, Pharmaceutical, General Medicine and Specialty Medicine, Pathology, Drug Discovery and Development
Triple Analysis: Colorectal Cancer, Leukemia and Prostate Cancer

Triple Analysis: Colorectal Cancer, Leukemia and Prostate Cancer

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Leukemia and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Drug and Medication
Triple Analysis: Colorectal Cancer, Lung Cancer and Prostate Cancer

Triple Analysis: Colorectal Cancer, Lung Cancer and Prostate Cancer

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Lung Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication, Drug Discovery and Development
Triple Analysis: Colorectal Cancer, Lymphoma and Prostate Cancer

Triple Analysis: Colorectal Cancer, Lymphoma and Prostate Cancer

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Lymphoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication
Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Prostate Cancer

Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Prostate Cancer

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Pancreatic Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication, Drug Discovery and Development
Triple Analysis: Colorectal Cancer, Prostate Cancer and Apoptosis

Triple Analysis: Colorectal Cancer, Prostate Cancer and Apoptosis

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Colorectal Cancer, Prostate Cancer and Angiogenesis

Triple Analysis: Colorectal Cancer, Prostate Cancer and Angiogenesis

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Prostate Cancer and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Colorectal Cancer, Prostate Cancer and Protein Kinase Inhibitors

Triple Analysis: Colorectal Cancer, Prostate Cancer and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Leukemia, Lung Cancer and Prostate Cancer

Triple Analysis: Leukemia, Lung Cancer and Prostate Cancer

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Leukemia, Lung Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria in ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Drug and Medication
Triple Analysis: Leukemia, Lymphoma and Prostate Cancer

Triple Analysis: Leukemia, Lymphoma and Prostate Cancer

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Leukemia, Lymphoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria in a five ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication
Triple Analysis: Leukemia, Pancreatic Cancer and Prostate Cancer

Triple Analysis: Leukemia, Pancreatic Cancer and Prostate Cancer

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Leukemia, Pancreatic Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Drug and Medication
Triple Analysis: Leukemia, Prostate Cancer and Apoptosis

Triple Analysis: Leukemia, Prostate Cancer and Apoptosis

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Leukemia and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Leukemia, Prostate Cancer and Angiogenesis

Triple Analysis: Leukemia, Prostate Cancer and Angiogenesis

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Leukemia and Prostate Cancer and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Leukemia, Prostate Cancer and Protein Kinase Inhibitors

Triple Analysis: Leukemia, Prostate Cancer and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Leukemia and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Lung Cancer, Lymphoma and Prostate Cancer

Triple Analysis: Lung Cancer, Lymphoma and Prostate Cancer

  • $ 5 175
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Lung Cancer, Lymphoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria in ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication
Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management

Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management

  • $ 3 500
  • Industry report
  • August 2012
  • by GBI Research

Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management Summary GBI Research, leading business intelligence provider has released its latest research ...

  • Industries : Drug Discovery and Development
Emerging Pharmaceutical Technologies - Stem cells

Emerging Pharmaceutical Technologies - Stem cells

  • $ 3 900
  • Industry report
  • August 2012
  • by CBR Pharma Insights

Stem cell technology is set to play a significant role in the pharmaceutical industry of the future. The opportunities for using stem cells across drug discovery, disease research, drug development and ...

  • Industries : Drug Discovery and Development, Biological Therapy, Pharmaceutical
Bioinformatics Research Market in India 2012

Bioinformatics Research Market in India 2012

  • $ 795
  • Industry report
  • August 2012
  • by Netscribes (India) Pvt. Ltd.

Currently at its initial stage, the bioinformatics research market in India is poised to become one of the fastest emerging areas in India. Rising R&D activities coupled with the favorable government activities ...

  • Industries : Drug Discovery and Development
  • Countries : India

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.